 Home > Active Ingredient News > Antitumor Therapy > Newly published data from Personalis, Inc. show that the new composite biomarker NEOPS™ can be used to predict the response of patients with advanced melanoma to cancer immunotherapy drugs

Newly published data from Personalis, Inc. show that the new composite biomarker NEOPS™ can be used to predict the response of patients with advanced melanoma to cancer immunotherapy drugs

 Last Update: 2021-08-13
 Source: Internet
 Author: User

Tags

normalize data set

blueberries cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Personalis, Inc.

Diagnosis is through the combined modeling of neoantigen load and immune- related drug resistance mechanisms to predict the response of melanoma to immunotherapy drugs through neoantigen load and immunity ⁽¹⁾Clinical Cancer Research

The study details the development of Personalis Neoantigen Presentation Score (NEOPS™)

Tumor immunity

Personalis Chief Medical Officer Richard Chen, MD said: “In view of the different responses to immunotherapy drugs and the potential toxicity associated with treatment, there is a need to improve biomarker methods to better predict which patients will respond to the treatment drugs

Precise

NEOPS uses the technology that Personalis has been developing since 2015 to better predict neoantigens and identify related escape mechanisms, such as HLA LOH

Forward-looking statements

All non-historical statements in this press release are "forward-looking statements" as defined by the U.

⁽¹⁾Clin Cancer Res August 1 2021 (27) (15) 4265-4276;DOI:10.

⁽¹⁾DOI:

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Wholesale Cheap Price Bulk Price Aclarubicin CAS 57576-44-0

CAS No.: 57576-44-0

$1/UNIT FOB

Vandetanib

CAS No.: 443913-73-3

Different Grade

$0.1/KG EXW

Camptothecin CAS 7689-03-4

CAS No.: 7689-03-4

Pharmacy Grade

$38-45/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.